APC	antigen presenting cells
BC	bladder cancer
BCG	Bacillus Calmette-Guérin
CTLA-4	cytotoxic T lymphocyte associated protein 4
DC	dendritic cell
DDR	DNA damage and response
DDR2	discoidin domain receptor tyrosine kinase 2
EMT	epithelial mesenchymal transition
FAP	fibroblast activation protein
HR-NMIBC	high-risk non-muscle invasive bladder cancer
ICI	immune checkpoint inhibitor
IFN- γ	interferon- γ
IHC	immunohistochemistry
LAG-3	lymphocyte activation gene-3
MDSC	myeloid derived suppressor cell
MHC-1	major histocompatibility complex I
MIBC	muscle-invasive bladder cancer
NAC	neoadjuvant chemotherapy
NK	natural killer cell
NMIBC	non-muscle invasive bladder cancer
OS	overall survival
PARP	poly ADP-ribose polymerase
PBC	platinum-based chemotherapy
pCR	pathological complete response
PD-1	programmed cell death protein 1
PD-L1	programmed death-ligand 1
PFS	progression-free survival
PLND	pelvic lymph node dissection
RB1	retinoblastoma protein 1
RC	radical cystectomy
RFS	recurrence-free survival
ROS	reactive oxygen species
STAT6	signal transducer and activator of transcription 6
TGF-β	transforming growth factor beta
TIGIT	T cell immunoglobulin and ITIM domain
TMB	tumor mutational burden
TME	tumor microenvironment
TURBT	transurethral resection of bladder tumor
VEGF	vascular endothelial growth factor